That could be debatable, at this moment in time.
I did buy
That could be debatable, at this moment in time.
I did buy 1500 shares on margin at $2.75 last week
and 1000 warrants with cash.
My margin shares are underwater and I would have to sell for a loss
My warrants are up $0.25 so I could sell for a gain.
If the pps dropped even lower, my margin loss would grow bigger whereas my warrant risk will always be the same.
But yes, in the long run you could make more with the margin shares
because I have to wait until $4.04 to convert warrants to break even
whereas with the $2.75 shars I would be up $1.29 at $4.04
Don't play warrants or margin unless you can afford the RISK.
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Soleno Therapeutics Engages Investors at February Conferences Soleno Therapeutics, Inc. (NASDAQ: SLNO), a dynamic player in the biopharmaceutical field, is set to make impactful appearances at a series of investor conferences coming up in February. Based in Redwood City, California, this clinical-stage company is renowned for its commitment to developing innovative...
Continue Reading
Small and mid-sized businesses feel every operational decision more sharply. A large company can absorb waste. A delayed order. A supplier mistake. A few bad purchases that sit unused. It hurts, but it rarely shakes the whole structure. For smaller businesses, the margin is tighter. Cash flow matters more. Time matters more. Trust matters more. One missed delivery can...
Continue Reading
Accelchain's Major Leap with Grant Acquisition Accelchain just scored a serious win, snagging a Decentralized Futures Grant that’s set to turbocharge their mission in developing decentralized applications (dApps) within the Polkadot ecosystem. This isn’t just another funding event; it’s a significant turning point that could ripple through the entire space....
Continue Reading
Exploring the Growth of the Medical Robots Market The medical robots market is poised for remarkable growth, projected to reach a staggering USD 34.32 billion by 2031. With a compound annual growth rate (CAGR) of 17.4% during the period from 2024 to 2031, several factors are driving this trend, including an increase in surgical procedures among the aging population and...
Continue Reading
Exploring the Resilience of Dividend Stocks In recent times, the performance of dividend stocks has showcased their resilience in the financial market. U.S. dividend stocks have consistently outperformed other sectors this year, especially those that typically lean towards growth. This shift in performance emphasizes the strength of traditionally dividend-oriented...
Continue Reading
